BODI Bodisen

RNS Number:8634T
Bodisen Biotech Inc
28 March 2007

               BODISEN BIOTECH, INC. ("BODISEN" OR THE "COMPANY")
                                  AMEX UPDATE



As previously announced on 20 March 2007, the Company stated that the American
Stock Exchange (the "Amex") intended to strike the common stock of the Company
from the Amex by filing a delisting application with the Securities and Exchange
Commission (the "SEC").  Although the Company has a limited right to appeal the
basis for the delisting determination, by requesting a hearing with an Amex
Listing Qualifications Panel, the Company has now determined not to appeal.


Currently, the Company's common stock is subject to a trading halt imposed by
Amex.  The Company expects the trading halt will remain in place pending the
Amex formally delisting the Company's common stock.  Following the formal
de-listing, the Company's common stock may become eligible for trading on the
OTC Bulletin Board.  The Company's common stock continues to be traded on AIM.


The Company will continue its business operations in the normal course
notwithstanding the status of the Amex listing.


As previously disclosed, the Company intends to provide additional information,
and will make further SEC filings as appropriate, regarding the equity interests
and the holdings of Qiong Wang and Bo Chen and possible third party claims once
the Company and its advisers complete their review of the Company's internal
records and any relevant documents, which remains ongoing at this time.



About Bodisen Biotech, Inc.


Bodisen Biotech Inc. is a leading manufacturer of liquid and organic compound
fertilizers, pesticides, insecticides and agricultural raw materials certified
by the Petroleum Chemical Industry Administrative office of China (Chemical
Petroleum Production Administrative Bureau), Shaanxi provincial government and
Chinese government.  The Company is headquartered in Shaanxi province and is a
Delaware corporation.  The Company's environmentally friendly "green" products
have been proven to improve soil and plant quality, and increase crop yields.


Enquiries:

Charles Stanley Securities
Richard Thompson / Philip Davies                        020 7953 2000




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCJPMLTMMJTMPR

Bodisen Biotech (LSE:BODI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Bodisen Biotech (LSE:BODI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024